Olympus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Olympus and buy or sell other stocks, ETFs, and their options commission-free!

About OCPNY

Olympus Corp. operates as a global medical technology company, that develops and provides innovative solutions for the early detection, diagnosis, and minimally invasive treatment of diseases. It operates through the following segments: Gastrointestinal Solutions, Surgical and Interventional Solution. 

CEO
Robert White, MBA
CEORobert White, MBA
Employees
28,138
Employees28,138
Headquarters
Tokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded
1919
Founded1919
Employees
28,138
Employees28,138

OCPNY Key Statistics

Market cap
20.06B
Market cap20.06B
Price-Earnings ratio
23.04
Price-Earnings ratio23.04
Dividend yield
1.71%
Dividend yield1.71%
Average volume
59.76K
Average volume59.76K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$13.73
52 Week high$13.73
52 Week low
$8.08
52 Week low$8.08

OCPNY News

Financial Times 6d
Olympus shares plunge 13% after FDA warning - Financial Times

...

Olympus shares plunge 13% after FDA warning - Financial Times
TipRanks 6d
Olympus Receives FDA Warning Letter but Sees No Financial Impact

Olympus ( (JP:7733) ) just unveiled an update. Olympus has disclosed that it received a Warning Letter from the U.S. Food and Drug Administration following ins...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.